
Please try another search
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Anthony S. Paek | - | - | Co-Founder & Executive Chairman |
Shu Kam Mok | 63 | - | Member of Advisory Board |
Young Kwang Chae | - | 2021 | Member of Advisory Board |
Scott Schubert | - | - | Member of Advisory Board |
Linda Moy | - | - | Member of Advisory Board |
Kyunghyun Cho | - | - | Member of Scientific Advisor |
Yung-Jue Bang | - | - | Member of Advisory Board |
Khan M. Siddiqui | 50 | - | Member of Advisory Board |
Mark S. Germain | 73 | 2021 | Member of Advisory Board |
Jihoon Jeong | - | - | Member of Advisory Board |
Eliot L. Siegel | - | - | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review